Curative Biosciences, Inc.
Curative Biosciences, Inc. (CBDX) PE Ratio — Current & Historical Data
Trailing twelve months (TTM) P/E, forward P/E, PEG, and annual PE history — from market prices and filings.
cbdx · pe ratio · data through Jun 30, 2017
Core PE Ratio Metrics
Trailing 12 months · TTMThe price-to-earnings (P/E) ratio for Curative Biosciences, Inc. (CBDX) measures how much investors pay for each dollar of the company's trailing earnings. CBDX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Source: FMP · /ratios-ttm · /analyst-estimates · 2017-06-30
PE Ratio History
2016 – 2017 · Annual▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare (Annual)
PE Ratio vs Peers
Drug Manufacturers - Specialty & Generic · 6 peers · Annual PE| Company | Market Cap | PE (Annual) | vs Avg | EPS (TTM) |
|---|---|---|---|---|
Curative Biosciences, Inc.You CBDX | $0M | N/A | — | -$0.00 |
 Acura Pharmaceuticals, Inc. ACUR | $0M | N/A | — | -$0.02 |
 Amazonas Florestal, Ltd AZFL | $0M | 16.39x | +98.7% | $0.00 |
 Cannonau Corp. CNNC | $0M | 0.11x | -98.7% | $0.14 |
 Filament Health Corp. FLHLF | $0M | N/A | — | -$0.02 |
 G Medical Innovations Holdings Ltd GMVDF | $0M | N/A | — | -$34.17 |
 Kali, Inc. KALY | $0M | N/A | — | -$0.00 |
Industry Average 2 peers with valid PE | — | 8.25x | baseline | — |
* N/A — Company is not profitable (TTM) · excluded from industry average · ▸ FMP /stock-peers + /ratios?limit=1 · priceToEarningsRatio
Annual PE Ratio History
| Fiscal Year End | PE Ratio | EPS (TTM) | YoY Change | PE vs Max |
|---|---|---|---|---|
2017-06-30Latest FY2017 | — | $-0.00 | — | |
2016-06-30 FY2016 | — | $-0.12 | — |
▸ FMP /ratios?period=annual&limit=20 · priceToEarningsRatio + netIncomePerShare · Zero extra API
About PE Ratio & Methodology
The price-to-earnings (P/E) ratio for Curative Biosciences, Inc. (CBDX) measures how much investors pay for each dollar of the company's trailing earnings. CBDX's current PE ratio of N/A is calculated by dividing its stock price of $0.00 by its TTM earnings per share of -$0.00.
Frequently asked questions
CBDX pe ratio · 6 questionsCBDX's current PE ratio is N/A as of 2026-06-09, based on a stock price of $0.00 and TTM EPS of -$0.00. Data sourced from Financial Modeling Prep via CBDX's SEC 10-K and 10-Q filings.
▸ Source: FMP · /ratios-ttm · /ratios annual · /analyst-estimates · /stock-peers · Curative Biosciences, Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: 2026-06-09